voice searchcamera search
Eribulin Mesylate Injection - 0.5 Mg/ml Solution For Injection | Targeted Cancer Treatment For Metastatic Breast Cancer, Suitable For Women, Requires Refrigeration, Side Effects Include Weakness And Peripheral Neuropathy

Eribulin Mesylate Injection - 0.5 Mg/ml Solution For Injection | Targeted Cancer Treatment For Metastatic Breast Cancer, Suitable For Women, Requires Refrigeration, Side Effects Include Weakness And Peripheral Neuropathy

Price Trend: 266.45-273.28 USD / Bottle

Get Latest Price

Minimum Order Quantity :

2 Bottle

Brand Name :

Ebunat

In Stock

In Stock

Product Specifications

Drug TypeInjection
IngredientsERIBULIN INJ
Physical FormPowder
FunctionCancer Treatment
Recommended ForBreast Cancer
DosageMissed Dose Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose. Overdose Seek emergency medical treatment or contact the doctor in case of an overdose.
Suitable ForWomen
Quantity10 Unit
Storage InstructionsREFRIGERATION( 2-8 c)
Payment TermsCash in Advance (CID)
Supply Ability50 Per Week
Delivery Time2 Week
Sample PolicySample costs shipping and taxes has to be paid by the buyer
Packaging Details2ML/VAIL
Main Export Market(s)Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America, Asia
Main Domestic MarketAll India

Product Overview

Key Features

Eribulin Mesylate Injection is used in the treatment of breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after the cancer has spread

Company Details

SHRESTHA GLOBAL PHARMA, Established in 2003 at Nagpur in Maharashtra, is a leading Exporter,Supplier,Trading Company of Common Medicines & Drugs in India. SHRESTHA GLOBAL PHARMA is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Ebunat (Eribulin Mesylate Solution for Injection0.5 mg/mL), SHRESTHA GLOBAL PHARMA has made a reputed name for itself in the market with high-quality 1.5 gm Meropenem and Sulbactam For Injection, 13.9% w/w Eflornithine, 300 mg Cefdinir Capsules, etc.
Focusing on a customer-centric approach, SHRESTHA GLOBAL PHARMA has a pan-India presence and caters to a huge consumer base throughout the country. Buy Common Medicines & Drugs in bulk from SHRESTHA GLOBAL PHARMA at Trade India quality-assured products.

Business Type

Exporter, Supplier, Trading Company

Employee Count

10

Establishment

2003

Working Days

Monday To Sunday

GST NO

27ADJPR6506L1Z1

Payment Mode

Cash in Advance (CID)

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 27ADJPR6506L1Z1

3 RatingRating

Nagpur, Maharashtra

Seller Inquiry

Accepts only Foreign inquiries

Proprietor

Mr Saroj Roy

Address

B No. 95, Aradhana Colony, Nara Road, Jaripatka, Nagpur, Maharashtra, 440014, India

anti cancer injection in Nagpur

Report incorrect details

Compare With Similar Products

Buyer Feedback

3

3

Price Or Price Range

266.45-273.28 USD ($) (Approx.)

3 USD ($) (Approx.)

1200 INR (Approx.)

Minimum Order Quantity

2 Bottle/Bottles

50 Pack/Packs

1 Piece/Pieces

Drug Type

Injection

General Medicines

Physical Form

Powder

Capsules

Function

Cancer Treatment

Cancer Treatment

Storage Instructions

REFRIGERATION( 2-8 c)

Cool & Dry Place

Payment Terms

Cash in Advance (CID)

Cash in Advance (CID), Cheque, Cash Advance (CA)

Letter of Credit (L/C), Paypal, Western Union, Telegraphic Transfer (T/T), Cash Against Delivery (CAD), Letter of Credit at Sight (Sight L/C), Others, Cash on Delivery (COD), Delivery Point (DP), Days after Acceptance (DA), Cash Advance (CA), Cash in Advance (CID), Cheque

Supply Ability

50 Per Week

30000 Per Month

Main Export Market(s)

Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America, Asia

Asia, South America, Eastern Europe, Western Europe, Middle East, Central America, North America, Australia, Africa

Main Domestic Market

All India

All India

All India

Sold By